The nod from the Canadian regulator comes after Remilk secured ‘no questions’ letters from the Food and Drug Administration in the US and the Singapore Food Agency respectively. It is the first company in the precision fermentation-derived dairy alternative proteins arena to receive an approval from the Canadian authorities.
Remilk’s animal-free BLG protein is claimed to be equivalent to its cow-derived counterpart, but is produced via precision fermentation without involving animals. The company manufactures its protein at commercial scale in several locations around the world.
Aviv Wolff, Remilk’s co-founder and CEO, said: “This is an important day for us at Remilk, and a historic one for Canada as it opens its doors to the new-dairy revolution. We developed a strategic roadmap for regulatory approvals around the world, recognizing that CPG companies seek solutions that benefit consumers throughout North America.
“We prioritized Canada in our regulatory strategy, following the green light from the FDA. Canada is an important market for us, and we are proud to be the first to enter.”
He said that the regulatory nod validates the ingredient’s safety and purity, as Canadian regulators were the fourth health administration to examine the protein.
He added: “We are now ready to partner with leading food companies in the country and offer consumers a whole new experience of guilt-free indulgence. Remilk’s animal-free protein represents a breakthrough. We’re creating the new generation of food that is not only delicious and nutritious, but significantly more sustainable, and kind to our planet and animals.”
